2.87
+0(+0.00%)
Currency In USD
| Previous Close | 2.87 |
| Open | 2.88 |
| Day High | 2.9 |
| Day Low | 2.79 |
| 52-Week High | 4.99 |
| 52-Week Low | 1.9 |
| Volume | 457,570 |
| Average Volume | 920,290 |
| Market Cap | 193.22M |
| PE | -3.63 |
| EPS | -0.79 |
| Moving Average 50 Days | 2.45 |
| Moving Average 200 Days | 2.73 |
| Change | 0 |
If you invested $1000 in Cardiff Oncology, Inc. (CRDF) 10 years ago, it would be worth $12.3 as of January 14, 2026 at a share price of $2.87. Whereas If you bought $1000 worth of Cardiff Oncology, Inc. (CRDF) shares 5 years ago, it would be worth $146.65 as of January 14, 2026 at a share price of $2.87.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025
GlobeNewswire Inc.
Dec 08, 2025 9:05 PM GMT
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that clinical data from an i
Cardiff Oncology to Present at Sidoti’s Year-End Virtual Investor Conference
GlobeNewswire Inc.
Dec 08, 2025 12:00 PM GMT
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will
Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 24, 2025 12:00 PM GMT
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will